Interim financial report for 1 January - 30 September 2021 for FirstFarms A/S
24 nov. 2021 02h47 HE | FirstFarms A/S
Satisfactory Q3 points to historic 2021 result The prices of crops have affected FirstFarms A/S' result in the first 3 quarters of 2021 positively, as FirstFarms annually is a large net seller...
Delårsrapport for 1. januar - 30. september 2021 for FirstFarms A/S
24 nov. 2021 02h47 HE | FirstFarms A/S
Tilfredsstillende 3. kvartal peger i retning af historisk 2021-resultatDe høje priser på afgrøder har påvirket FirstFarms A/S resultat positivt i de første 3 kvartaler af 2021, da FirstFarms på...
Immatics Announces Third Quarter 2021 Financial Results and Provides Business Update
16 nov. 2021 07h00 HE | https://immatics.com/
Interim data update at SITC for ongoing ACTengine® IMA203 trial targeting PRAME demonstrated clinical responses across multiple solid tumor types during dose escalation phaseImmatics to initiate three...
Immatics veröffentlicht Ergebnisse des dritten Quartals 2021 sowie ein Update zur Geschäftsentwicklung
16 nov. 2021 07h00 HE | Immatics N.V.
Laufende ACTengine® IMA203-Studie: Zelltherapie gegen PRAME erzielt therapeutischen Anti-Tumor-Effekt in verschiedenen soliden Tumoren bereits in Dosis-EskalationsphaseImmatics plant drei...
Australian Water Technology Company Shows Rapid Growth in First Quarter as a Public Company
09 nov. 2021 19h07 HE | Clean TeQ Water
MELBOURNE, Australia, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Clean TeQ Water recently released its first quarterly report since publicly listing on the Australian Securities Exchange. It currently has...
GenTech-Colour-Trans-800x400.png
GenTech Posts Strong Quarterly Report Featuring Breakout Growth in Revenues & Inventory on Hand coupled with large Decreases in Liabilities
15 sept. 2021 09h15 HE | GenTech Holdings Inc.
NEW YORK, Sept. 15, 2021 (GLOBE NEWSWIRE) -- GenTech Holdings, Inc. (OTC Pink: GTEH) (“GenTech” or the “Company”), an emerging leader in the Functional Foods and Nutritional Supplement marketplaces,...
Immatics Announces Second Quarter 2021 Financial Results and Provides Business Update
10 août 2021 07h00 HE | https://immatics.com/
ACTengine® patient recruitment remains on track; as of end of July, a total of 27 patients have been treated with IMA201, IMA202 or IMA203 across different cancer indicationsTCR Bispecifics pipeline...
Immatics veröffentlicht Ergebnisse des zweiten Quartals 2021 sowie ein Update zur Geschäftsentwicklung
10 août 2021 07h00 HE | Immatics N.V.
Patientenrekrutierung für die ACTengine®-Studien verläuft weiterhin nach Plan; bis Ende Juli wurden insgesamt 27 Patienten mit unterschiedlichen Krebserkrankungen mit den Produktkandidaten IMA201,...
grapefruit LOGO.png
Grapefruit USA Reports Cannabis Bumper Crop, Lower Demand due to Pandemic and Economic Uncertainty Contributed to Small Year-over-Year Revenue Decrease
25 mai 2021 15h24 HE | Grapefruit USA Inc.
LOS ANGELES and DESERT HOT SPRINGS, Calif., May 25, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Grapefruit USA, Inc., (“GPFT,” “Grapefruit” or the “Company”) (OTCQB: GPFT) a California based...
Immatics Announces First Quarter 2021 Financial Results and Business Update
18 mai 2021 07h00 HE | https://immatics.com/
Data update for ongoing ACTengine® IMA200 clinical trial series demonstrated first anti-tumor activity in heavily pre-treated solid cancer patients during early phases of dose escalationNext...